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Foxp3þ T-regulatory cells (Tregs) may suppress pathogenic
inflammation; however, although transferred Tregs lessen
glomerulonephritis in mice, the role of endogenous foxp3þ
cells is not known. To study this, we characterized
endogenous foxp3þ cells in accelerated anti-glomerular
basement membrane (GBM) nephritis by using foxp3GFP
reporter mice to track their responses in early and
established disease. Further, diphtheria toxin was used to
ablate foxp3þ Tregs in foxp3DTR mice after establishing
an immune response. In this model, mice were immunized
with sheep globulin in adjuvant, and sheep anti-mouse GBM
globulin was injected after 4 days to initiate progressive
histological and functional injury. Intrarenal leukocytic
infiltrates were increased by day 3 but intrarenal foxp3þ
Tregs, present in interstitial and periglomerular areas, were
only increased at day 7. Ablation of foxp3þ Tregs after
injection of anti-GBM globulin increased renal injury and
systemic T-cell responses, including increased interferon-c
and interleukin-17A (IL-17A) production, but no change in
antibody titers. Compared with foxp3þ Tregs isolated from
naive mice, those from immunized mice produced more IL-10
and more effectively regulated CD4þ foxp3 responder
T cells. Thus, endogenous foxp3þ Tregs infiltrate the kidney
in glomerulonephritis, and deleting foxp3þ cells after the
induction of immune responses upregulated T-cell reactions
and enhanced disease. Hence, endogenous foxp3þ cells
have increased suppressive capacity after immune stimuli.
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T cells that express the transcription factor foxp3 are a
regulatory subset of CD4þ helper T cells, necessary for the
maintenance of peripheral tolerance1,2 and immune homeo-
stasis.3,4 Foxp3þ T-regulatory cells (Tregs) are the most well-
characterized subset of Tregs, but not all subsets of Tregs
express foxp3.5 Foxp3þCD4þ cells are reciprocally linked
with the development of Th17 effector cells,6,7 and recent
studies suggest that these foxp3þ Tregs cells can regulate
both Th1-8 and Th17-9mediated effector responses. In
experimental murine glomerulonephritis, both Th1 and
Th17 effector subsets, and their respective signature cyto-
kines, interferon-g (IFN-g) and interleukin-17A (IL-17A),
can mediate severe glomerular disease.10–13
In renal autoimmunity, regulation of autoreactive T-cell
responses to the Goodpasture antigen by CD4þCD25þ
T cells has been demonstrated in convalescent Goodpasture’s
disease patients.14 In murine models of crescentic
glomerulonephritis, transfer of exogenous naive CD4þ
CD25þ T cells before induction of nephritis attenuates
disease,15 and affecting the migration of Tregs to secondary
lymphoid organs16 or the kidney17 worsens injury. In murine
models of toxic and ischemic renal injury, transfer of foxp3-
transduced CD4þ cells or naive CD25þ cells, or anti-CD25
antibody administration, attenuates injury.18–24
Although studies suggest a role for foxp3þ Tregs in
suppressing renal disease, most have focused on cell transfer;
therefore, any role for endogenous foxp3þ cells in limiting
glomerular disease directed by antigen-specific CD4þ cells
has not been demonstrated directly. This question can be
addressed using foxp3GFP reporter mice25 and foxp3DTR
mice.4 Foxp3GFP mice25 possess a green fluorescent protein
(GFP)–foxp3 fusion protein-reporter knock-in allele that
allows foxp3þ cells to be identified and isolated for
functional experiments. Foxp3DTR mice4 express the human
diphtheria toxin (DT) receptor under the control of the foxp3
locus, allowing specific ablation of this regulatory T-cell
subset on administration of DT.
The aim of the current studies is to define the role of
endogenous foxp3þ Tregs in anti-glomerular basement
membrane (GBM) nephritis.26 The availability of foxp3DTR
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mice allows depletion of Tregs after initiating an immune
response to the nephritogenic antigen (in this model,
sheep globulin). Previously used strategies for depleting
endogenous Tregs using anti-CD25 antibodies would, in this
situation, deplete effector T cells as well.27 The availability of
foxp3DTR mice, used in the current studies, overcomes this
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Figure 1 |Histological and functional renal injury at days 3 and 7 in accelerated anti-GBM nephritis using foxp3GFP reporter mice.
Accelerated anti-glomerular basement membrane (GBM) nephritis was induced in foxp3GFP mice that were culled on day 3 or day 7. Control
mice (ctrl) were immunized but did not receive sheep anti-GBM globulin. (a–c) Representative periodic acid-Schiff (PAS) stains of glomerular
cross-sections at high power,  400, showing no histological abnormalities in ctrl mice, mild glomerular necrosis in day 3 mice, and more
severe necrosis with crescent formation in day 7 mice. (d–f) PAS staining of the tubulointerstitial compartment at low power,  200,
showing no tubulointerstitial injury in ctrl mice, mild tubular dilation with some cast formation present in day 3 mice, and tubular atrophy
with markedly increased cast formation and cellular infiltrate in day 7 mice. Assessments of histological renal injury show (g) glomerular
necrosis, (h) glomerular crescents, and (i) tubulointerstitial in ctrl, day 3, and day 7 mice. (j) Proteinuria and (k) hematuria levels, measured
by urine test strips. *Po0.05, **Po0.01, and ***Po0.001 by analysis of variance, Tukey’s post-test.
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problem by allowing specific deletion of Tregs on the basis
of their lineage-specific expression of foxp3.
RESULTS
Endogenous foxp3þ Tregs infiltrate the kidney by day 7,
not day 3, of glomerulonephritis
Renal injury and infiltrates in this model of accelerated anti-
GBM disease were characterized using foxp3GFP reporter
mice.24 Mice were immunized with normal sheep globulin 4
days before intravenous injection of sheep anti-GBM
globulin on day 0, and humanely killed on day 3 or 7.
Control mice were immunized with sheep globulin, and
killed on day 7. Mice injected with anti-GBM globulin
developed focal and segmental necrosis, glomerular crescent
formation, tubulointerstitial injury (tubular dilation and
atrophy, sloughing of tubular epithelial cells and cast forma-
tion), proteinuria and hematuria (described in Figure 1).
Immunochemical staining revealed glomerular CD4þ T cells,
macrophages, and neutrophils at day 3 but no further
increase at day 7 (Figure 2a, c and e) and progressively
increased numbers of tubulointerstitial CD4þ cells, macro-
phages, and neutrophils (Figure 2b, d and f).
Immunohistological staining for foxp3 on paraffin-
embedded kidney sections showed that foxp3þ Tregs were
rarely found in control or in day 3 mice but were readily
detected in day 7 mice, predominantly in periglomerular and
tubulointerstitial areas (Figure 3a–f and g). Foxp3þ cells were
rarely found in glomeruli. Using flow cytometry, endogenous
foxp3GFP numbers were increased at day 7 (compared with
control and day 3 mice; Figure 3h). As a proportion of all
intrarenal leukocytes (CD45þ cells), foxp3þ Tregs were
increased at day 7 compared with control and day 3 mice: 1.9
versus 1.1 and 1.2%, respectively (Figure 3i). As a proportion
of intrarenal CD4þ T cells, compared with control, foxp3þ
Tregs were decreased at day 3, but increased by day 7: 11.0,
7.3, and 13.8%, respectively (Figure 3j). Representative
flow cytometry plots of the intrarenal CD45þ cells, gated
on CD4þ and foxp3GFPþ cells, are shown in Figure 3k. Dual
immunofluorescence confocal microscopy of kidney sections
stained with an antigen-presenting cell-conjugated anti-
CD4þ antibody (using endogenous GFP expressed by
foxp3GFP mice) confirmed the presence of intrarenal
CD4þ foxp3þ Tregs in kidneys of day 7 mice (Figure 4a–c).
Foxp3þ Tregs in the draining inguinal lymph nodes
enumerated by flow cytometry and expressed as a proportion
of CD45þ or CD4þ cells were not different between control,
day 3, and day 7 groups (Table 1). There was a trend toward a
decrease in the total number of foxp3þ Tregs and an increase
in foxp3þ Tregs as a proportion of CD45þ cells. In this
model of anti-GBM nephritis, the majority of foxp3þ Tregs
in the kidney and inguinal draining lymph nodes were
CD25þ , whereas others were CD25 (Supplementary
Figure S1 online). By day 7, a higher proportion of foxp3þ
cells in the kidney were CD25 compared with control mice.
Depletion of endogenous foxp3þ Tregs after induction of
anti-GBM nephritis exacerbates disease
Foxp3DTR mice were studied to determine the role of
endogenous foxp3þ Tregs in the effector phase of disease.
Mice were immunized with normal sheep globulin, then after
4 days injected with sheep anti-mouse GBM globulin.
Foxp3þ Tregs were ablated in foxp3DTR mice by intra-
peritoneal 1 mg DT injections after anti-GBM globulin
on the day of injection, with further injections after 24 and
72 h, according to previously published protocols.4,28 This
depletion strategy ensured that immune responses to sheep
globulin had been established, with depletion occurring after
the induction of anti-GBM nephritis. Control C57BL/6 wild-
type (WT) mice with glomerulonephritis received equal
doses of DT. WT mice developed moderate histological
disease at day 10, characterized by glomerular focal and
segmental necrosis, crescent formation, and tubulointerstitial
injury. All disease parameters were exacerbated in foxp3DTR
mice after depleting foxp3þ Tregs (Figure 5a–h).
Compared with WT mice, endogenous foxp3þ depletion
in foxp3DTR mice resulted in an increase in CD4þ T cells,
macrophages, and neutrophils both in glomeruli and the
tubulointerstitium (Figure 6a–f). The proportions and
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Figure 2 | Infiltration of cellular effectors into glomerular and
tubulointerstitial compartments in early, day 3, and
established, day 7, disease. Immunohistological staining on
periodate lysine paraformaldehyde-fixed frozen kidney sections of
renal (a, b) CD4þ T cells, (c, d) macrophages, and (e, f) neutrophils
in control (ctrl), day 3, and day 7 mice. *Po0.05, **Po0.01,
***Po0.001 by analysis of variance, Tukey’s post-test. gcs,
glomerular cross-section; hpf, high-power field.
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activation status of intrarenal CD4þ T cells were analyzed by
flow cytometry. As a proportion of CD45þ cells, foxp3DTR
mice had increased CD4þ cells (Figure 7a and b), but
proportions of intrarenal CD4þ cells expressing the effector
memory phenotype (CD4þCD44þ ) were unchanged
(Figure 7c and d).
Systemic immune responses are enhanced after foxp3þ cell
depletion in an established immune response
Supernatant from sheep globulin-stimulated splenocyte
cultures was analyzed by cytometric bead array for IFN-g,
IL-17A, tumor necrosis factor, and IL-6. The prototypic Th1
cytokine IFN-g or the Th17 cytokine IL-17A was not detected
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Figure 3 | Foxp3þ Tregs have infiltrated the kidney only by day 7. Representative diaminobenzidine (black) staining for foxp3 on
formalin-fixed kidney sections (a–c) around glomeruli and (d–f) within the tubulointerstitium, at high power  400, in control (ctrl), day 3,
and day 7 mice. Arrows show foxp3-positive staining. (g) Quantification of renal foxp3þ T-regulatory cells (Tregs) by immunohistology.
(h) Enumeration of foxp3þ Tregs by flow cytometry in a whole kidney. (i) Foxp3þ Tregs presented as a proportion of renal CD45þ cells and
(j) Foxp3þ Tregs presented as a proportion of renal CD4þ cells. (k) Illustrative FACS plot showing populations of CD4þ cells on the y axis
and foxp3þ cells on the x axis (numbers within quadrants are the respective percentages) in ctrl, day 3, and day 7 mice. *Po0.05 and
**Po0.01 by analysis of variance, Tukey’s post-test. hpf, high-power field.
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in splenocyte supernatants from WT mice (limit of assay:
20 pg/ml), but both were found in supernatants from all
foxp3DTR mice (Figure 8a and b). Tumor necrosis factor and
IL-6 were also increased in foxp3DTR mice (Figure 8c and d).
Titers of mouse anti-sheep immunoglobulin G (IgG)
antibodies were unchanged in foxp3DTR mice (Figure 8e).
CD4þ effector T cells were assessed in lymph nodes by
removing the draining inguinal lymph nodes at day 10,
counting cell numbers, then analyzing the proportions of
CD4þCD44þ effector memory T cells. Compared with WT
mice, foxp3þ cell-depleted mice had more total leukocytes in
the draining nodes (Figure 9a). The proportion of CD4þ
T cells within the lymph node cell population was not
different between groups, but foxp3þ cell-depleted mice
had a higher proportion of CD4þ cells expressing CD44
(Figure 9b–d).
Foxp3þ Tregs from mice immunized with sheep globulin
have increased immunosuppressive capacity
To determine whether endogenous foxp3þ Tregs have an
increased suppressive capacity following immune stimula-
tion, the potency of ‘activated’ foxp3þ Tregs (from
immunized mice) in suppressing effector T-cell responses
was compared with that of naive foxp3þ Tregs. Responder
CD4þ foxp3 T cells from sheep globulin-immunized mice
were cultured with either CD4þ foxp3þ Tregs from naive
mice or with CD4þ foxp3þ Tregs from mice immunized
with sheep globulin. Different foxp3þ Treg/responder T-cell
ratios were used, with mitomycin C-treated, CD4-depleted
naive splenocytes, and sheep IgG included in cultures.
Compared with foxp3þ Tregs from naive mice, foxp3þ
Tregs from immunized mice had a greater capacity to inhibit
proliferation of CD4þ foxp3 responder T cells (Figure 10a).
IFN-g secretion from CD4þ foxp3 responder T cells was
suppressed below the assay’s detection limit (20 pg/ml) when
cocultured with foxp3þ Tregs from immunized mice, but
was detectable at a ratio of 1:16 and 1:8 when mixed with
foxp3þ Tregs from naive mice (Figure 10b). Tregs from
immunized mice were also more potent inhibitors of IL-17A
(Figure 10c). IL-2 and tumor necrosis factor secretion levels
were also markedly reduced by foxp3þ Tregs and more
effectively with Tregs from immunized mice. Tregs (2 104
cells) from immunized mice secreted more IL-10 when
cultured without responder T cells compared with foxp3þ
Tregs from naive mice (Figure 10f). At a ratio of 1:2 (foxp3þ
Treg (1 104 cells) to responder T cells (2 104 cells)), IL-10
was still detectable in immunized mice Tregs, but only
marginally detectable in naive Treg cocultures.
DISCUSSION
The role of endogenous Tregs in nephritis has not yet been
defined. The current studies characterize the evolution of a
T-regulatory cell response by endogenous foxp3þ Tregs
during early inflammatory injury, at day 3, and when disease
is established, at day 7, and demonstrates that depleting
endogenous foxp3þ Tregs after the induction of immune
responses enhances T-cell effector responses and leads to
more severe glomerulonephritis. Furthermore, following
immunization, foxp3þ Tregs have an increased ability to
regulate helper T effector-mediated responses.
In this model of anti-GBM nephritis, mice were
immunized with sheep globulin to induce an immune
response against this antigen, and renal disease was triggered
using sheep anti-mouse GBM globulin. In a similar model of
nephritis, nephritic kidneys exhibited increased foxp3þ Tregs
at day 7.17 However, whether these endogenous foxp3þ Tregs
CD4+/foxp3+Foxp3+CD4+
Figure 4 |Detection of intrarenal CD4þ foxp3 cells and CD4þ foxp3þ T-regulatory cells using dual immunofluorescence confocal
microscopy in established disease. Kidney sections from mice with established anti-glomerular basement membrane nephritis (day 7)
were stained with anti-CD4 antibodies, and foxp3þ cells were identified by green fluorescent protein expression. (a) CD4þ cells (red).
(b) Foxp3þ cells (green). (c) Merge: double-positive cells (yellow arrows) are seen along with single-positive CD4þ foxp3 cells (red).
Micrographs were taken at  600.
Table 1 | Foxp3+ T-regulatory cell numbers and proportions
of CD45+ and CD4+ cells in the draining lymph node
CD4+foxp3+ CD4+foxp3+ CD4+foxp3+
No. ( 103) CD45+ (%) CD4+ (%)
Ctrl 28.3±6.8 1.29±0.1 5.65±0.4
Day 3 30.2±10.2 1.20±0.1 5.40±0.5
Day 7 13.3±4.3 1.68±0.2 5.40±0.6
Abbreviations: Ctrl, control; Tregs, T-regulatory cells.
Total numbers of foxp3+ Tregs were enumerated by flow cytometry from the two
inguinal draining lymph nodes and expressed as proportions of CD45+ as well as
CD4+ cells in control-immunized mice at day 3 or at day 7.
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were recruited into the kidney before or after effector cell
infiltrates was not known. Tracking of foxp3þ Tregs at days 3
and 7 within the kidney by immunohistology and flow
cytometry showed that intrarenal foxp3þ Tregs are increased
in the kidney only at day 7, but not at day 3. As a proportion
of CD4þ cells, foxp3þ Tregs are decreased at day 3,
consistent with the influx of CD4þ foxp3 effector helper
T cells into the kidney. Confocal microscopy confirmed that
foxp3þCD4þ cells were readily found in the kidney at day 7.
Therefore, tracking of endogenous renal foxp3þ Tregs in the
early and established phase of disease suggests that intrarenal
foxp3þ Tregs are unlikely to be important at the onset of
nephritis but could be relevant after nephritic insult by
cellular effectors has occurred. In the draining lymph nodes,
total numbers of foxp3þ Tregs and foxp3þ Treg percentages
as proportions of CD45þ or CD4þ were not significantly
different between control, day 3, and day 7 mice, but there
was a trend to decreased numbers of foxp3þ Tregs at day 7,
which may reflect emigration of Tregs from the node.
Before the development of foxp3DTR mice, studies in other
models of disease have used anti-CD25 antibodies to deplete
Tregs.29 This method does not deplete CD25 foxp3þ
cells,2,25 and, in the context of an active immune response,
may deplete activated T cells.27 It is likely that depleting
foxp3þ cells before a nephritogenic immune response was
established would enhance the subsequent adaptive immune
response and therefore injury. However, as using foxp3DTR
mice means that Tregs can be depleted specifically, we sought
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photomicrographs of periodic acid-Schiff (PAS)-stained sections at
high power ( 400) in (a) WT mice showing some segmental
necrosis and (b) Foxp3DTR mice showing more severe necrosis and
early crescent formation. PAS-stained sections showing the
tubulointerstitium at lower power ( 200) in (c) WT mice showing
mild tubular dilation and some cast formation, and (d) foxp3DTR
mice showing more severe tubular dilation, tubular atrophy, and
more cast formation. PAS-stained kidney sections were assessed
for (e) glomerular necrosis, (f) glomerular crescents, and (g)
tubulointerstitial injury. (h) Proteinuria was assessed on a 24-h
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to address the role of endogenous foxp3þ cells in the
context of an active immune response. In the current studies,
foxp3þ Treg ablation after inducing nephritogenic immune
responses led to more severe glomerulonephritis. Although
there was also an increase in renal CD4þ T cells as a
proportion of CD45þ cells, the proportion of CD4þ T cells
that were CD4þCD44þ effector memory phenotype was
similar, showing that endogenous foxp3þ Tregs limited
recruitment to the kidney of both CD44þ and CD44
CD4þ cells.
Systemic immunity to the nephritogenic antigen, mea-
sured by splenocyte cytokine production, showed that
ablation of endogenous foxp3þ Tregs resulted in increased
Th1 and Th17 cytokines (IFN-g and IL-17A), as well as in
increased proinflammatory cytokines tumor necrosis factor
and IL-6. The increase in both IFN-g and IL-17A suggests
that, in this model, foxp3þ Tregs regulate both Th1 and
Th17 effector subsets. In the draining lymph node, foxp3DTR
mice had increased total number of cells and a marked
increase in the proportions of CD4þ T cells that were
CD4þCD44þ effector memory T cells, showing that foxp3þ
Tregs regulate T-cell activation in secondary lymphoid organs
in this model.16 The timing of the depletion of foxp3þ cells,
after the induction of immune responses, allowed the
development of intact humoral immunity, as serum anti-
sheep IgG levels were unchanged.
The near absence of Tregs in glomeruli of mice with
glomerulonephritis in this model, together with the markedly
increased systemic T-cell response, implies, at least in the
glomerular lesion, that Tregs exert their effects predominantly
within secondary lymphoid organs. However, the presence of
intrarenal Tregs within the tubulointerstitium raises the
possibility of an additional local role for Tregs in regulating
the tubulointerstitial component of this disease.
The availability of foxp3GFP reporter allows for Tregs to be
isolated from an activated immune system and used in
functional assays without compromising viability. Reliably
isolating regulatory T cells for functional assays was
previously possible only in naive mice, as selecting Tregs on
the basis of CD25 expression meant that in active immune
responses effector CD4þ cells expressing CD25 would be
included as ‘regulatory’ cells.27 In our ex vivo coculture
experiments, foxp3þ Tregs from immunized mice were
better at suppressing T-cell effector functions (proliferation
and secretion of proinflammatory cytokines) than were Tregs
from naive mice. This increased suppressive effect of foxp3þ
Tregs from immunized mice suggests that endogenous Tregs
upregulate their suppressive function in response to immune
stimuli. Tregs from immunized mice secreted more IL-10,
consistent with studies showing that this anti-inflammatory
cytokine regulates disease in this model.30 The effects of
foxp3þ Tregs from naive mice when cocultured at higher
ratios of Tregs to T-responder cells are consistent with those
of previous experiments demonstrating that transfer of
exogenous CD4þCD25þ Tregs before inducing an immune
response results in suppression of nephritis.15
In conclusion, the current studies characterize the
infiltration of endogenous foxp3þ Tregs into the kidney,
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demonstrate their necessity in attenuating glomerulo-
nephritis, and show that foxp3þ Tregs upregulate their
regulatory capacity in nephritogenic inflammation.
MATERIALS AND METHODS
Experimental design
Foxp3GFP female mice (n¼ 4 per group) were housed at Monash
Animal Services (Melbourne, Australia). Age- and sex-matched
foxp3DTR mice (n¼ 6), and control C56BL/6J mice (n¼ 5) were
housed at the Institute for Molecular Medicine and Experimental
Immunology, Bonn, Germany. Accelerated anti-GBM glomerulo-
nephritis was induced by immunizing mice subcutaneously with
0.5 mg (100 ml) of sheep globulin in Freund’s complete adjuvant
(100 ml) at day 4, followed by intravenous injection of sheep
anti-mouse GBM globulin (0.15 or 0.20 mg/g) at day 0. Mice were
humanely killed at day 3, 7, or 10. Foxp3þ Tregs were specifically
ablated by injection of DT (Merck, Darmstadt, Germany) at days 0,
1, and 3. Control C57BL/6 mice with glomerulonephritis received
equal doses of DT at the same time points. This method of foxp3þ
cell depletion achieved an efficiency of B90% when measured by
flow cytometry at day 4 in the kidney, inguinal draining lymph
nodes, and spleen (Supplementary Figure S2 online). Animal studies
were conducted under specific pathogen-free conditions and
approved by the Monash University Animal Ethics Committee or
the German Institutional and Government Review Boards. Results
are expressed as means±s.e.m. Statistical analyses were conducted
using analysis of variance when comparing three groups, followed by
Tukey’s post-test or Student’s unpaired t-test when comparing two
groups, *Po0.05, **Po0.01, ***Po0.001 (GraphPad Prism;
GraphPad Software, San Diego, CA).
Assessment of renal injury and immune cell infiltration
Glomerular necrosis and crescents and tubulointerstitial injury were
assessed on 3 mm-thick, periodic acid-Schiff-stained, Bouin’s-fixed,
paraffin-embedded sections, X50 glomeruli per mouse. Glomerular
necrosis was defined as accumulation of periodic acid-Schiff-
positive material in X50% of the glomerulus, and glomerular
crescents as two or more layers of cells in Bowman’s space.
Tubulointerstitial injury was assessed in 15 randomly selected
cortical areas from each animal at  250 magnification using a
10 mm2 graticule, and defined as tubular dilation, tubular atrophy,
sloughing of tubular epithelial cells, and cast formation. Injury was
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graded according to a scale of 0–4: grade 0, 0%, grade 1, 0–25%;
grade 2, 25–50%, grade 3; 50–75%; and grade 4, 75–100% of the
tubulointerstitium injured. Urine was collected either by bladder
puncture at the time of death or by metabolic cage 24 h before
death. Proteinuria and hematuria was measured by Combur-Test
strips (Roche Diagnostics, Castle Hill, Australia) or proteinuria by
modified Bradford’s method as previously described.31
CD4þ T cells, macrophages, and neutrophils were shown by
immunoperoxidase staining of 6mm-thick, periodate lysine parafor-
maldehyde-fixed, frozen kidney sections as previously described.32
Foxp3 was detected on formalin-fixed paraffin-embedded 3mm
sections. The primary monoclonal antibodies used were GK1.5
(anti-mouse CD4; American Type Culture Collection, Manassas, VA),
FA/11 (macrophages, anti-mouse CD68; from Dr Gordon L.
Koch, Cambridge, England), RB6–8C5 (neutrophils, anti-Gr-1),
and anti-mouse foxp3 (FJK-16s; eBiosciences, San Diego, CA), with
rabbit anti-rat biotin as a secondary antibody (BD Biosciences, North
Ryde, Australia). To enumerate positive-stained cells, X20 consecu-
tively viewed glomeruli and X15 high-power cortical interstitial
fields (excluding perivascular regions) were assessed per animal as
described previously.32 Confocal images were captured using a
NikonC1 inverted confocal laser and Nikon Ti-E scanning microscope
from 6mm SNAP frozen sections, blocked with 10% rat serum in
5% bovine serum albumin/phosphate buffered saline before incubat-
ing with antigen-presenting cell-conjugated CD4 antibodies
(eBioscience).
Isolation of leukocytes and flow cytometry
Kidneys were digested with 1 mg/ml collagenase D (Roche
Diagnostics) and 0.1 mg/ml DNAse I (Roche Diagnostics) in RPMI
1640/10% fetal calf serum (Invitrogen, Mount Waverley, Australia)
and 10 mmol/l HEPES (4-(2-hydroxyethyl)-1-piperazineethane-
sulfonic acid). Spleens and lymph nodes were minced and
filtered, erythrocytes lysed with ammonium chloride, and viability
assessed by trypan blue staining. Single cell suspensions were
stained with antibodies against CD4, CD25, CD44, and CD45
(all BD Biosciences). Foxp3þ cells were assessed by endogenous
GFP expression. Propidium iodide or Hoechst-positive cells were
excluded from analyses. Total cells were enumerated with BD
Calibrite Beads (BD Biosciences). Cell data were acquired on
FACSCanto flow cytometer (BD Biosciences) and analyzed with
FlowJo software (Tree Star, Ashland, OR).
Measurement of systemic immune responses
Cytokines were measured from supernatants of cultured splenocytes
using single cell suspensions of splenocytes from each mouse.
Splenocytes were cultured for 72 h (24-well tissue culture plates,
1 ml aliquots, 4 106cells/ml, RPMI-1640, 10% fetal calf serum, 1%
penicillin/streptomycin, 2 mmol/l L-glutamine, 50 mmol/l 2-mercap-
toethanol), with 10 mg/ml protein G-purified sheep IgG, as
previously described32,33 using a BD Cytometric Bead Array Mouse
Th1/Th2/Th17 Cytokine kit according to the manufacturer’s
instructions (BD Biosciences). Spleens from each individual
mouse in both groups were assessed for proportions of CD4þ cells
and CD4þ foxp3þ cells. The proportions of CD4þ cells and
CD4þ foxp3þ Tregs in the spleen were similar between WT and
foxp3DTR mice at day 10 (CD4þ WT 16.2±3.0, foxp3DTR 14.9±1.7,
of CD45þ splenocytes; CD4þ foxp3þ WT 3.5±0.8, foxp3DTR
3.5±0.3, of CD4þ cells), consistent with previous published data
showing the return of CD4þ foxp3þ Tregs to normal levels after
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Figure 10 |Compared with foxp3þ Tregs from naive mice, foxp3þ Tregs from sheep globulin-immunized mice better suppress
cell-mediated responses and secrete more IL-10 ex vivo. Foxp3þ T-regulatory cells (Tregs) from lymph nodes were isolated either from
mice immunized with sheep globulin or from naive mice, and their capacity to inhibit cell-mediated responses from CD4þ foxp3 responder
T cells measured using a coculture assay. Responder T cells were cultured at a concentration of 2 104 cells per well with increasing ratios
of foxp3þ Tregs (1:16 to 1:1) in the presence of antigen-presenting cells and stimulating antigen sheep globulin. (a) [3H]-thymidine
proliferation, and secretion of proinflammatory cytokines (b) IFN-g, (c) IL-17A, (d) IL-2, and (e) TNF, as well as secretion of anti-inflammatory
(f) IL-10 from Tregs. Inhibition of responses from responder T cells and IL-10 secretion from foxp3þ cells were compared. APC, antigen-
presenting cells without foxp3þ Tregs or responder T cells; IFN-g, interferon-g; IL, interleukin; ND, not detected; TNF, tumor necrosis factor;
Treg, 2 104 foxp3þ Tregs without responder T cells. *Po0.05, **Po0.01, and ***Po0.001 by Student’s t-test.
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5–10 days after DT injections.4 In separate experiments, cytokines
were measured from cocultures of foxp3þ Treg cells (from
immunized or naive foxp3GFP mice) with foxp3 responder cells
at the ratios indicated. Circulating mouse anti-sheep IgG levels
were assessed from serum as described previously33 using horse-
radish peroxidase-conjugated sheep anti-mouse IgG (1:800 dilution,
Amersham Biosciences, Rydalmere, Australia).
Coculture of CD4þ foxp3þ Tregs with CD4þ foxp3
responder cells
CD4þ cells were isolated by magnetic cell sorting according to the
manufacturer’s instructions (MACS CD4þ T cell Isolation Kit;
Miltenyi Biotec, North Ryde, Australia), followed by sorting based
on GFP expression using cell sorter, Beckman Coulter MoFlo XDP
(Beckman Coulter, Gladesville, Australia). CD4þ foxp3 responder
T cells (2 104) were cocultured with increasing amounts of
CD4þ foxp3þ Tregs (1.25 103–2 104) and with erythrocyte-
lysed, MACS CD4-depleted, mitomycin C-treated (50 mg/ml,
30 min, 37 1C, then washed repeatedly) splenocytes (8 104) and
100mg/ml sheep IgG in 96-well round-bottom plates for 72 h. [3H]-
thymidine (0.5 mCi) was added per well for the last 16 h of culture
and proliferation measured as counts per million, using a liquid
scintillation b-counter (Cambridge Scientific, Cambridge, MA).
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